We aime to: (1) characterize the longitudinal evolution of DTI-ALPS indices, PVS burden, and CP volumes from subacute to chronic phases post-stroke; and (2) determine whether these biomarkers predict functional outcome and PSCI at 6-month follow-up. The gene discussed is CP; the disease is Stroke.